Klotho Neurosciences Inc logo

Klotho Neurosciences Inc Share Price Today (NASDAQ: KLTO)

Klotho Neurosciences Inc share price is 0.17 & ₹14.41 as on 13 May 2025, 2.30 'hrs' IST

$0.17

0.01

(4.82%)

Market is closed - opens 7 PM, 13 May 2025

View live Klotho Neurosciences Inc share price in Dollar and Rupees. Guide to invest in Klotho Neurosciences Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Klotho Neurosciences Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Klotho Neurosciences Inc share price movements

  • Today's Low: $0.15
    Today's High: $0.33

    Day's Volatility :53.95%

  • 52 Weeks Low: $0.11
    52 Weeks High: $0.99

    52 Weeks Volatility :88.54%

Klotho Neurosciences Inc (KLTO) Returns

PeriodKlotho Neurosciences IncIndex (Russel 2000)
3 Months
-48.67%
0.0%
6 Months
-51.5%
0.0%
1 Year
-97.11%
0.0%
3 Years
-98.22%
-1.3%

Klotho Neurosciences Inc (KLTO) Key Statistics

in dollars & INR

Previous Close
$0.1661
Open
$0.1662
Today's High
$0.3294
Today's Low
$0.1517
Market Capitalization
$17.6M
Today's Volume
$21.6M
52 Week High
$0.99
52 Week Low
$0.1135
Revenue TTM
$0.0
Earnings Per Share (EPS)
$0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Klotho Neurosciences Inc Stock (KLTO) from India?

It is very easy for Indian residents to invest directly in Klotho Neurosciences Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Klotho Neurosciences Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Klotho Neurosciences Inc or KLTO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Klotho Neurosciences Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Klotho Neurosciences Inc shares which would translate to 4.986 fractional shares of Klotho Neurosciences Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Klotho Neurosciences Inc, in just a few clicks!

Returns in Klotho Neurosciences Inc (KLTO) for Indian investors in Rupees

The Klotho Neurosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Klotho Neurosciences Inc investment value today

Current value as on today

₹4,340

Returns

₹95,660

(-95.66%)

Returns from Klotho Neurosciences Inc Stock

₹97,181 (-97.18%)

Dollar Returns

₹1,521 (+1.52%)

Indian investors sentiment towards Klotho Neurosciences Inc (KLTO)

-29%

Period: Apr 12, 2025 to May 12, 2025. Change in 30 Days versus previous period

Search interest for Klotho Neurosciences Inc Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Klotho Neurosciences Inc

Rating
Trend

Insights on KLTO Stock (Ticker Symbol: KLTO)

  • Price Movement

    In the last 3 months, KLTO stock has moved down by -52.8%
  • KLTO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 79.9% return, outperforming this stock by 177.0%
  • KLTO vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.2% return, outperforming this stock by 211.4%

Klotho Neurosciences Inc (KLTO) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Regeneron Pharmaceuticals, Inc. logo
0.72%
-29.94%
-41.12%
-12.19%
0.76%
Vertex Pharmaceuticals Incorporated logo
-11.36%
-10.31%
2.22%
72.91%
58.66%
Alnylam Pharmaceuticals, Inc. logo
12.33%
0.24%
79.87%
115.9%
97.94%

About Klotho Neurosciences Inc

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates comprise KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Organization
Klotho Neurosciences Inc
Employees
3
CEO
Dr. Joseph Sinkule Pharm.D.
Industry
Miscellaneous

Management People of Klotho Neurosciences Inc

NameTitle
Dr. Joseph Sinkule Pharm.D.
Founder, CEO, Chairman of the Board & Secretary
Mr. Jeffrey LeBlanc
Chief Financial Officer
Mr. Peter J. Moriarty
COO & Chief Business Officer
Dr. Shalom Z. Hirschman M.D.
Medical Advisor & Director
Dr. Miguel Chillon Rodriguez
Chief Scientific Advisor & Consultant
Dr. Bradford A. Navia M.D., Ph.D.
Chief Medical Advisor

Important FAQs about investing in KLTO Stock from India :

Can Indians buy Klotho Neurosciences Inc shares?

Yes, Indians can invest in the Klotho Neurosciences Inc (KLTO) from India.

With INDmoney, you can buy Klotho Neurosciences Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Klotho Neurosciences Inc at zero transaction cost.

How can I buy Klotho Neurosciences Inc shares from India?

It is very easy to buy Klotho Neurosciences Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Klotho Neurosciences Inc (KLTO) be purchased?

Yes, you can buy fractional shares of Klotho Neurosciences Inc with INDmoney app.

What are the documents required to start investing in Klotho Neurosciences Inc stocks?

To start investing in Klotho Neurosciences Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Klotho Neurosciences Inc share price today?

Klotho Neurosciences Inc share price today stands at $0.17, Open: $0.17 ; Previous Close: $0.17 ; High: $0.33 ; Low: $0.15 ; 52 Week High: $0.99 ; 52 Week Low: $0.11.

The stock opens at $0.17, after a previous close of $0.17. The stock reached a daily high of $0.33 and a low of $0.15, with a 52-week high of $0.99 and a 52-week low of $0.11.

What are today’s High and Low prices of Klotho Neurosciences Inc Stock (KLTO)?

Today’s highest price of Klotho Neurosciences Inc (KLTO) is $0.33.

Today’s lowest price of Klotho Neurosciences Inc (KLTO) is $0.15.

What is the 52 Week High and Low Range of Klotho Neurosciences Inc Stock (KLTO)?

  • 52 Week High

    $0.99

  • 52 Week Low

    $0.11

What are the historical returns of Klotho Neurosciences Inc (KLTO)?

  • 1 Month Returns

    -4.54%

  • 3 Months Returns

    -51.5%

  • 1 Year Returns

    -97.11%

  • 5 Years Returns

    -98.24%

What is today's market capitalisation of Klotho Neurosciences Inc?

Today's market capitalisation of Klotho Neurosciences Inc KLTO is 17.6M

Who is the Chief Executive Officer (CEO) of Klotho Neurosciences Inc ?

Dr. Joseph Sinkule Pharm.D. is the current Chief Executive Officer (CEO) of Klotho Neurosciences Inc.